Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The purpose of this study was to assess the single-dose relative bioavailability study of 1 mg risperidone orally disintegrating tablets and (Risperdal M-TAB) under fasting conditions.
Epistemonikos ID: e3352b7326e28465225aef3192a8b1a3cb48a167
First added on: May 05, 2024